Inactive Instrument

MediPal Holdings Corporation Stock Other OTC

Equities

MAHLY

US58502T1079

Pharmaceuticals

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2024 * 3,527B 22.82B Sales 2025 * 3,561B 23.04B Capitalization 521B 3.37B
Net income 2024 * 35.7B 231M Net income 2025 * 35.68B 231M EV / Sales 2024 * 0.15 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.15 x
P/E ratio 2024 *
14.7 x
P/E ratio 2025 *
14.9 x
Employees -
Yield 2024 *
2.42%
Yield 2025 *
2.52%
Free-Float 84.27%
More Fundamentals * Assessed data
Dynamic Chart
MediPal Holdings Corporation agreed to acquire PreMedica Inc. from Noritsu Koki Co., Ltd. for ¥3.8 billion. CI
Tranche Update on MediPal Holdings Corporation's Equity Buyback Plan announced on May 12, 2023. CI
MediPal Holdings Corporation's Equity Buyback announced on May 12, 2023 has closed with 4,171,900 shares, representing 1.97% for ¥9,999.86 million. CI
Tranche Update on MediPal Holdings Corporation's Equity Buyback Plan announced on May 12, 2023. CI
MEDIPAL Holdings Corporation and JCR Pharmaceuticals Co., Ltd. Conclude Two Agreements on Mucopolysaccharidosis Type IIIB Treatment CI
Tranche Update on MediPal Holdings Corporation's Equity Buyback Plan announced on May 12, 2023. CI
MediPal Holdings Corporation Reports Earnings Results for the Full Year Ended March 31, 2023 CI
MediPal Holdings Corporation announces an Equity Buyback for 5,800,000 shares, representing 2.71% for ¥10,000 million. CI
MediPal Holdings Corporation authorizes a Buyback Plan. CI
Japan Index Rises on Oil Price Surge; Polaris Appoints President, CFO MT
Sumitomo Pharma Closes Sale of Food, Chemical Subsidiary to Medipal MT
MediPal Holdings Corporation acquired Toshichi Co.,Ltd. CI
MediPal Holdings Corporation completed the acquisition of Sumitomo Pharma FOOD & CHEMICAL Co., LTD. from Sumitomo Pharma Co., Ltd.. CI
Layered Co., Ltd. announced that it has received funding from MediPal Holdings Corporation, FFG Venture Business Partners Co., Ltd. CI
Nichi-Iko Pharmaceutical Secures 98.5 Billion Yen of Debt Relief, Plans 20 Billion Yen Share Allotment; Shares Plunge 20% MT
More news
Managers TitleAgeSince
President 72 00-03-31
Compliance Officer - -
Compliance Officer - -
Members of the board TitleAgeSince
President 72 00-03-31
Director/Board Member 61 10-05-31
Director/Board Member 69 77-03-31
More insiders
MEDIPAL HOLDINGS CORPORATION engages in the wholesale of pharmaceutical products, cosmetics and daily miscellaneous goods. The Company operates in three segments. The Ethical Pharmaceutical Wholesale segment is involved in the wholesale of pharmaceutical products, medical equipment and test reagents, the distribution and planning of specialty drugs, the construction of medical material database and others. The Cosmetics, Daily Product and General Medicine Wholesale segment is engaged in the wholesale of cosmetics, daily miscellaneous goods and general pharmaceuticals. The Veterinary Medicine and Food Processing Raw Materials Wholesale segment is engaged in the wholesale of veterinary products, food additives and food raw materials. The Company is also involved in the provision of cleaning services, the management and operation of logistics centers, the provision of manpower dispatching services and others.
Calendar
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW